Friday, July 10, 2026

Drug profile · INN

milnacipran

milnacipran (IMPULSOR) is a norepinephrine transporter inhibitor.

EMA: refused
Patents linked 3
Pipeline programs 1
News articles 0
Drug details — milnacipran
Class
Route
Patents
3
Programs
1
Data quality
0.83

Quick answer

milnacipran (IMPULSOR) is a norepinephrine transporter inhibitor.

Key facts

INN milnacipran
Brand IMPULSOR
Mechanism Norepinephrine transporter inhibitor

Mechanism of action

Norepinephrine transporter inhibitor

Approval history

Authority Status Date
EMA refused

Pipeline programs

  1. INTENSIFY MDD Phase 3 · Disc Medicine · Major depressive disorder

Related patents

  1. US 8021687

    Modified release compositions of milnacipran

    Expires Mon Sep 15 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  2. US 7704527

    Modified release compositions of milnacipran

    Expires Mon Apr 22 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  3. US 7038085

    Stereoisomers of p-hydroxy-milnacipran, and methods of use thereof

    Expires Mon Apr 27 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

Frequently asked questions

What is milnacipran?

milnacipran (IMPULSOR) is a norepinephrine transporter inhibitor.

What is the brand name for milnacipran?

IMPULSOR is a marketed brand name for milnacipran. Check FDA Drugs@FDA for the current US label holder and prescribing information.